By Denny Jacob
Bionano Genomics agreed to the purchase and sale of its common stock.
The San Diego genome analysis solutions provider will purchase and sell about 8.7 million shares and warrants to purchase an equivalent amount of shares at a price of $1.145 per share.
The gross proceeds to the company from the offering are expected to be about $10 million before fees and expenses, which it intends to use for measures including research and development expenses. The offering is expected to close on or about April 8.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 04, 2024 14:00 ET (18:00 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments